Rights and Permissions
Cortellini A, Dettorre GM, Dafni U, et alImmune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registriesJournal for ImmunoTherapy of Cancer 2022;10:e005732. doi: 10.1136/jitc-2022-005732
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made.
Cortellini, Alessio; Dettorre, Gino M; and et al., "Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries." Journal for ImmunoTherapy of Cancer. 10, 11. e005732 (2022).